These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 32961235)

  • 21. Dietary fiber of Tartary buckwheat bran modified by steam explosion alleviates hyperglycemia and modulates gut microbiota in db/db mice.
    He X; Li W; Chen Y; Lei L; Li F; Zhao J; Zeng K; Ming J
    Food Res Int; 2022 Jul; 157():111386. PubMed ID: 35761642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of liraglutide in treatment of non-alcoholic fatty liver disease: mechanism of action and research advances].
    Liu Y; Feng PP; Zhu W; Gong JP
    Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):473-476. PubMed ID: 28763870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.
    Luo L; Fang K; Dan X; Gu M
    Lipids Health Dis; 2019 Jan; 18(1):11. PubMed ID: 30621686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Rich-Polyphenols Extract of Dendrobium loddigesii on Anti-Diabetic, Anti-Inflammatory, Anti-Oxidant, and Gut Microbiota Modulation in db/db Mice.
    Li XW; Chen HP; He YY; Chen WL; Chen JW; Gao L; Hu HY; Wang J
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30544624
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: A pilot randomized trial.
    Khoo J; Hsiang J; Taneja R; Law NM; Ang TL
    Diabetes Obes Metab; 2017 Dec; 19(12):1814-1817. PubMed ID: 28503750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal flora in clinical trial.
    Hui D; Liu L; Azami NLB; Song J; Huang Y; Xu W; Wu C; Xie D; Jiang Y; Bian Y; Sun M
    Front Endocrinol (Lausanne); 2022; 13():1107071. PubMed ID: 36743913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: A randomized trial.
    Feng WH; Bi Y; Li P; Yin TT; Gao CX; Shen SM; Gao LJ; Yang DH; Zhu DL
    J Diabetes Investig; 2019 Mar; 10(2):399-407. PubMed ID: 29957886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease.
    Tang W; Yao X; Xia F; Yang M; Chen Z; Zhou B; Liu Q
    Oxid Med Cell Longev; 2018; 2018():7261619. PubMed ID: 30671174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liraglutide protects against inflammatory stress in non-alcoholic fatty liver by modulating Kupffer cells M2 polarization via cAMP-PKA-STAT3 signaling pathway.
    Li Z; Feng PP; Zhao ZB; Zhu W; Gong JP; Du HM
    Biochem Biophys Res Commun; 2019 Feb; 510(1):20-26. PubMed ID: 30683312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver Lipidomics Analysis Revealed the Protective mechanism of Zuogui Jiangtang Qinggan Formula in type 2 diabetes mellitus with non-alcoholic fatty liver disease.
    Zhou M; Liu X; Wu Y; Xiang Q; Yu R
    J Ethnopharmacol; 2024 Jul; 329():118160. PubMed ID: 38588985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet.
    Zhu W; Feng PP; He K; Li SW; Gong JP
    Biochem Biophys Res Commun; 2018 Oct; 505(2):523-529. PubMed ID: 30269815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis.
    Duparc T; Briand F; Trenteseaux C; Merian J; Combes G; Najib S; Sulpice T; Martinez LO
    Am J Physiol Gastrointest Liver Physiol; 2019 Oct; 317(4):G508-G517. PubMed ID: 31460789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].
    Zhao XY; Zhang LL; Suolang QZ; Yang GY; Li L; Li SB; Chen WW
    Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):849-53. PubMed ID: 25531383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cilostazol Attenuates Hepatic Steatosis and Intestinal Disorders in Nonalcoholic Fatty Liver Disease.
    Min T; Qiu S; Bai Y; Cao H; Guo J; Su Z
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liraglutide Decreases Liver Fat Content and Serum Fibroblast Growth Factor 21 Levels in Newly Diagnosed Overweight Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.
    Li X; Wu X; Jia Y; Fu J; Zhang L; Jiang T; Liu J; Wang G
    J Diabetes Res; 2021; 2021():3715026. PubMed ID: 34660809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacteroides ovatus alleviates high-fat and high-cholesterol -induced nonalcoholic fatty liver disease via gut-liver axis.
    Sun C; Xiong X; Liu M; Liang Q; Zhao Q; Wei G; Shi J; Li X
    Biomed Pharmacother; 2024 Sep; 178():117156. PubMed ID: 39032286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin supplementation alleviates hepatic fat content associated with modulation of gut microbiota-dependent bile acid metabolism in patients with nonalcoholic simple fatty liver disease: a randomized controlled trial.
    He Y; Chen X; Li Y; Liang Y; Hong T; Yang J; Cao Z; Mai H; Yao J; Zhang T; Wu K; Zou J; Feng D
    Am J Clin Nutr; 2024 Jul; 120(1):66-79. PubMed ID: 38795741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
    Shen SH; Zhong TY; Peng C; Fang J; Lv B
    BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Featured article: Structure moderation of gut microbiota in liraglutide-treated diabetic male rats.
    Zhang Q; Xiao X; Zheng J; Li M; Yu M; Ping F; Wang T; Wang X
    Exp Biol Med (Maywood); 2018 Jan; 243(1):34-44. PubMed ID: 29171288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice.
    Zhuge A; Li S; Lou P; Wu W; Wang K; Yuan Y; Xia J; Li B; Li L
    Microbiol Spectr; 2022 Jun; 10(3):e0004722. PubMed ID: 35647690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.